Earnings


  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker catching up on orders, manufacturing after cyberattack

    CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.

    By July 31, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific again cuts 2026 guidance

    Challenges in the electrophysiology and Watchman businesses led the medtech company to cut its sales and earnings per share forecasts for the second quarter in a row.

    By July 29, 2026
  • A Philips factory
    Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips largely recoups struck-down Trump tariffs in Q2

    The company recovered 186 million euros after it “largely completed the U.S. tariff refund process” in the quarter, CEO Roy Jakobs said on an earnings call.

    By July 28, 2026
  • An image of Edwards Lifesciences' campus in Irvine, California.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion

    An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with moderate disease are expected to help the company maintain its momentum.

    By July 24, 2026
  • A clinician wearing blue scrubs and a mask stands near a da Vinci 5 robotic system in an operating room.
    Image attribution tooltip
    Permission granted by Staten Island University Hospital
    Image attribution tooltip

    Intuitive ties Q2 procedure softness to ACA subsidy expirations

    Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.

    By July 17, 2026
  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Exact Sciences/Business Wire
    Image attribution tooltip

    Abbott reports diagnostics growth since $21B Exact Sciences buy

    The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.

    By July 16, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J misses company expectations for cardiovascular in Q2

    Sales in Johnson & Johnson’s Abiomed business declined in the second quarter due to procedure volume pressures related to its Impella device.

    By July 15, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic boosts revenue by nearly double digits in Q4

    Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.

    By June 3, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed expands Abbott partnership to add dual glucose-ketone sensor

    In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.

    By June 3, 2026
  • Professional photo of William Berry, smiling in a suit, with a yellow stripe in the background.
    Image attribution tooltip
    Retrieved from Stryker on May 21, 2026
    Image attribution tooltip

    Stryker’s chief accounting officer to retire

    William Berry Jr. will retire in September, with Corporate Controller Emily Baculik stepping into the role.

    By May 21, 2026
  • An office building with a horizontal design and landscaping in front.
    Image attribution tooltip
    Courtesy of Carl Zeiss Meditec
    Image attribution tooltip

    Carl Zeiss says restructuring could affect up to 1,000 jobs

    A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.

    By May 15, 2026
  • A group of people stands in Times Square in front of a large ad thaqt says "Welcome to NASDAQ Mobia Medical."
    Image attribution tooltip
    Permission granted by Mobia Medical
    Image attribution tooltip

    Mobia Medical CEO eyes large market for stroke rehab

    With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.

    By May 11, 2026
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD appoints Vitor Roque as permanent CFO

    The company made Roque’s appointment permanent after considering external candidates for the role.

    By May 11, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem to file tubeless insulin pump with FDA this quarter

    The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.

    By May 8, 2026
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet raises revenue expectations for 2026

    CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.

    By May 6, 2026
  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker cyberattack ‘meaningfully’ impacted Q1

    CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.

    By May 1, 2026
  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer Biomet CFO departs for new job

    Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.

    By April 28, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards raises 2026 forecast as TAVR sales surge

    The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.

    By April 24, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific slashes 2026 guidance

    CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including electrophysiology and Watchman.

    By April 22, 2026
  • A modern office building with large reflective glass windows is shown behind a wide driveway and landscaped entrance. In the foreground, a white and orange monument sign reads "Intuitive Surgical" with the number "1020" vertically on the side.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Intuitive Surgical lifts 2026 outlook for da Vinci robot procedure growth

    The company, whose shares climbed nearly 8% Wednesday morning, also said a recent cyber incident has been contained and did not significantly affect first-quarter results.

    By April 22, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed posts double-digit sales growth, widening net loss

    New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault wrote.

    By April 21, 2026
  • A person wearing goggles and holding a clipboard looks at a tray in a laboratory.
    Image attribution tooltip
    Courtesy of Exact Sciences
    Image attribution tooltip

    Abbott lowers earnings forecast after $21B Exact Sciences buy

    CEO Robert Ford said the companies are a good cultural fit and he expects demand for Exact’s colon cancer screening test to increase.

    By April 16, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s cardiovascular unit stands out again in Q1

    Johnson & Johnson’s strategic shift to higher growth medical device markets like cardiovascular is paying off, as the business was the only medtech unit to grow by double digits in the first quarter.

    By April 14, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    Medtronic lowers earnings forecast after MiniMed IPO

    The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.

    By March 25, 2026
  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant buys MetaSight for $59M upfront to acquire blood test tech

    MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

    By Feb. 23, 2026